These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 23698361)

  • 21. Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDEδ.
    Ozdemir ES; Jang H; Gursoy A; Keskin O; Nussinov R
    J Phys Chem B; 2018 Aug; 122(30):7503-7513. PubMed ID: 29961325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PDEδ Binding to Ras Isoforms Provides a Route to Proper Membrane Localization.
    Muratcioglu S; Jang H; Gursoy A; Keskin O; Nussinov R
    J Phys Chem B; 2017 Jun; 121(24):5917-5927. PubMed ID: 28540724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Simulations of Solved Co-crystallized X-Ray Structures Identify Action Mechanisms of PDEδ Inhibitors.
    Salmas RE; Mestanoglu M; Yurtsever M; Noskov SY; Durdagi S
    Biophys J; 2015 Sep; 109(6):1163-8. PubMed ID: 26340817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit
    Kaya P; Schaffner-Reckinger E; Manoharan GB; Vukic V; Kiriazis A; Ledda M; Burgos Renedo M; Pavic K; Gaigneaux A; Glaab E; Abankwa DK
    J Med Chem; 2024 Jun; 67(11):8569-8584. PubMed ID: 38758695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thermodynamic, dynamic and solvational properties of PDEδ binding to farnesylated cystein: a model study for uncovering the molecular mechanism of PDEδ interaction with prenylated proteins.
    Suladze S; Ismail S; Winter R
    J Phys Chem B; 2014 Jan; 118(4):966-75. PubMed ID: 24401043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring binding modes of the selected inhibitors to phosphodiesterase delta by all-atom molecular dynamics simulations and free energy calculations.
    Zhong H; Zhang YJ; Shan XB
    J Biomol Struct Dyn; 2019 Jun; 37(9):2415-2429. PubMed ID: 30052144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells.
    Ji Z; Mei FC; Xie J; Cheng X
    J Biol Chem; 2007 May; 282(19):14048-55. PubMed ID: 17353198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis of recognition of farnesylated and methylated KRAS4b by PDEδ.
    Dharmaiah S; Bindu L; Tran TH; Gillette WK; Frank PH; Ghirlando R; Nissley DV; Esposito D; McCormick F; Stephen AG; Simanshu DK
    Proc Natl Acad Sci U S A; 2016 Nov; 113(44):E6766-E6775. PubMed ID: 27791178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural Biology-Inspired Discovery of Novel KRAS-PDEδ Inhibitors.
    Jiang Y; Zhuang C; Chen L; Lu J; Dong G; Miao Z; Zhang W; Li J; Sheng C
    J Med Chem; 2017 Nov; 60(22):9400-9406. PubMed ID: 28929751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma.
    Mottini C; Tomihara H; Carrella D; Lamolinara A; Iezzi M; Huang JK; Amoreo CA; Buglioni S; Manni I; Robinson FS; Minelli R; Kang Y; Fleming JB; Kim MP; Bristow CA; Trisciuoglio D; Iuliano A; Del Bufalo D; Di Bernardo D; Melisi D; Draetta GF; Ciliberto G; Carugo A; Cardone L
    Cancer Res; 2019 Nov; 79(21):5612-5625. PubMed ID: 31492820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression.
    Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y
    Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer.
    Mazur PK; Reynoird N; Khatri P; Jansen PW; Wilkinson AW; Liu S; Barbash O; Van Aller GS; Huddleston M; Dhanak D; Tummino PJ; Kruger RG; Garcia BA; Butte AJ; Vermeulen M; Sage J; Gozani O
    Nature; 2014 Jun; 510(7504):283-7. PubMed ID: 24847881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis.
    Santana-Codina N; Roeth AA; Zhang Y; Yang A; Mashadova O; Asara JM; Wang X; Bronson RT; Lyssiotis CA; Ying H; Kimmelman AC
    Nat Commun; 2018 Nov; 9(1):4945. PubMed ID: 30470748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer.
    Henry KE; Dacek MM; Dilling TR; Caen JD; Fox IL; Evans MJ; Lewis JS
    Clin Cancer Res; 2019 Jan; 25(1):166-176. PubMed ID: 30228208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A subset of metastatic pancreatic ductal adenocarcinomas depends quantitatively on oncogenic Kras/Mek/Erk-induced hyperactive mTOR signalling.
    Kong B; Wu W; Cheng T; Schlitter AM; Qian C; Bruns P; Jian Z; Jäger C; Regel I; Raulefs S; Behler N; Irmler M; Beckers J; Friess H; Erkan M; Siveke JT; Tannapfel A; Hahn SA; Theis FJ; Esposito I; Kleeff J; Michalski CW
    Gut; 2016 Apr; 65(4):647-57. PubMed ID: 25601637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel PDEδ interacting proteins.
    Küchler P; Zimmermann G; Winzker M; Janning P; Waldmann H; Ziegler S
    Bioorg Med Chem; 2018 May; 26(8):1426-1434. PubMed ID: 28935183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity.
    Leung ELH; Luo LX; Liu ZQ; Wong VKW; Lu LL; Xie Y; Zhang N; Qu YQ; Fan XX; Li Y; Huang M; Xiao DK; Huang J; Zhou YL; He JX; Ding J; Yao XJ; Ward DC; Liu L
    Cell Death Dis; 2018 Feb; 9(2):216. PubMed ID: 29440631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arl2-GTP and Arl3-GTP regulate a GDI-like transport system for farnesylated cargo.
    Ismail SA; Chen YX; Rusinova A; Chandra A; Bierbaum M; Gremer L; Triola G; Waldmann H; Bastiaens PI; Wittinghofer A
    Nat Chem Biol; 2011 Oct; 7(12):942-9. PubMed ID: 22002721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KRAS(G12D)- and BRAF(V600E)-induced transformation of murine pancreatic epithelial cells requires MEK/ERK-stimulated IGF1R signaling.
    Appleman VA; Ahronian LG; Cai J; Klimstra DS; Lewis BC
    Mol Cancer Res; 2012 Sep; 10(9):1228-39. PubMed ID: 22871572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.